ASA Biopharm's Podcast

In this podcast series sponsored by Biopharmaceutical Section of American Statistical Association, key opinion leaders from pharmaceutical industry and regulatory agencies talk about upcoming statistical conferences and events, and discuss current issues in Biopharmaceutical statistics.

http://community.amstat.org/BioP/Home/

Eine durchschnittliche Folge dieses Podcasts dauert 44m. Bisher sind 81 Folge(n) erschienen.
subscribe
share





Episode 80: 2020 Regulatory-Industry Statistics Workshop


Yabing Mai and Thomas Birkner discuss the 2020 Workshop and the changes necessary to go virtual.


share







   47m
 
 

Episode 79: Nusrat Rabbee


Nusrat discusses biomarker analysis throughout clinical development and her recent book Biomarker Analysis in Clinical Trials with R.


share







 2020-07-31  1h7m
 
 

Episode 78: Challenges with Pain Assessments


Dottie Brown, Ciprian Crainiceanu, and Jean Recta discuss how pain is quantified in human and animal trials.


share







 2020-06-30  54m
 
 

Episode 77: National Institute of Statistical Sciences


Nancy Flournoy, Dan Holder, and Jim Rosenberger discuss the mission and history of the National Institute of Statistical Sciences and how it will adapt for the future.


share







 2020-05-29  54m
 
 

Episode 76: COVID-19 and Clinical Trials


Mouna Akacha, Yongming Qu, and Aileen Ward discuss COVID-19 and the operational and statistical effects on clinical trials.


share







 2020-04-15  46m
 
 

Episode 75: Meijuan Li


Meijuan Li discusses precision medicine, diagnostic devices, and the importance of parallel development of drugs and diagnostics. 


share







 2020-03-31  52m
 
 

Episode 74: Glen Colopy and the Pod of Asclepius


Glen discusses his graduate training in data science in the United Kingdom, vital sign monitoring, the challenges of efficient drug supply, and his healthcare technology podcast, the Pod of Asclepius. 


share







 2020-02-28  47m
 
 

Episode 73: Bruce Binkowitz


Bruce discusses the Japanese regulatory environment, challenges for statistics departments spread across the globe, and his hopes and plans for the Biopharmaceutical Section in 2020.


share







 2020-02-03  44m
 
 

Episode 72: Abie Ekangaki


Abie discusses opportunities for statisticians in the CRO industry, and we chat about the Scholarship and Leadership-in-Practice Committees of the Biopharmaceutical Section.


share







 2019-12-31  56m
 
 

Episode 71: P-values in Medical Product Development


Lisa LaVange, J. Jack Lee, and Steve Ruberg about the ASA Statement on p-values, and their recent paper entitled “Inference and Decision Making for 21st-Century Drug Development and Approval” which was featured in the American Statistician in early 2019. 


share







 2019-12-02  59m